Beiersdorf Innovation Fund
Corporate VCHamburg · Seed–Growth · 6 people tracked
Investment thesis
Beiersdorf Venture Capital backs breakthrough ideas, technologies and business models that could shape the future of the skin care industry, investing at the intersection of life sciences, AI, sustainability, and consumer technology where scientific breakthroughs meet consumer impact. It takes minority stakes of up to 20%, typically at Series A but from early to growth stage, with initial tickets of €0.5–5.0M and follow-on capacity. Beyond capital, portfolio companies gain hands-on collaboration with Beiersdorf's R&D teams, deep cosmetics category expertise across the product lifecycle, and access to 170+ markets via global brands like NIVEA, Eucerin and La Prairie.
Source: firm website, verified Aug 16, 2026.
Team · 6 people
from the firm's websiteWhat they invest in
from 14 of 17 portfolio companiesBiotech ×9AI & Machine Learning ×4Healthtech ×4New Materials ×4Cleantech ×3Longevity ×3Circular Economy ×2Climate Tech ×2
HQs:Germany×2Switzerland×1France×1United Kingdom×1United States×1
Investments · 17 tracked
founders shown can be your intro pathcellvie develops Therapeutic Mitochondria Transplantation, a technique that augments or replaces failing mitochondria to restore cellular energy metabolism, with initial applications in ischemia-reperfusion injury (starting with kidney transplantation) and in mitochondria-enabled gene therapy for the genetic skin disease Epidermolysis Bullosa.
BiotechLongevityMedical Devices
Co-investorsTaiho Ventures, LLC
DeepLife is an AI techbio company that develops digital twin technology to simulate cellular behavior and disease mechanisms at the single-cell level.
AI & Machine LearningBiotechDeep TechParis, FR
Jean Baptiste Morlot(CTO)inJonathan Baptista(CEO)inJean-Baptiste Morlot(CTO)
Co-investorsEntrepreneur FirstKima VenturesYZR Capital
DePoly develops a chemical recycling technology that converts unsorted, contaminated PET plastic waste into virgin-grade raw materials (PTA and MEG precursors) for producing new plastics without fossil fuels.
Circular EconomyCleantechNew MaterialsSion, CH
Co-investorsCrane Venture PartnersInfinity Recycling
Dermanostic is an online dermatology service where patients upload photos and information about a skin condition and receive a medical assessment from a dermatologist, typically within a few hours.
Digital HealthHealthtech
Co-investorsDvH VenturesEnjoyventure Management
Emerald is a venture capital investor focused on complex, science-driven technology sectors, backing entrepreneurs and companies working on innovations such as energy, data centers, and grid-related technology.
CleantechClimate TechEnergy
Evommune develops therapies targeting the underlying sources of chronic inflammatory diseases, aiming to provide underserved patient populations with more than symptomatic relief.
BiotechHealthtechPalo Alto, US
Luis Pena(Executive Officer, Director)Janice Drew(Executive Officer)David Cohen(Director)Gregory Moss(Executive Officer)Eugene Bauer(Executive Officer, Director)Francois Beaubien(Director)
Co-investorsAndera PartnersAvego BioScience CapitalB Capital GroupB4 CapitalFemHealth VenturesLongwood Fund+2 more
Macro Biologics designs, patents, and produces advanced biomaterials for applications in healthcare, clean food and water, and packaging.
BiotechHealthtechNew Materials
Melt&Marble develops fats and lipids using precision fermentation and molecular lipid design, producing ingredients with controlled fatty acid composition for food and personal care applications.
BiotechFoodTechNew Materials
Co-investorsCatalyze CapitalChalmers Ventures ABIndustrifondenLever VCNordic Foodtech VC
NCA is a venture-client and early-stage investment firm that connects B2B startups with corporate partners to run pilots and scale validated demand.
Revent is a venture capital firm that partners with founders building companies focused on planetary and societal health, targeting health/care, education and finance, and sustainable consumption.
Climate TechImpact & Social Good
ReVentas develops a dissolution-based recycling technology that dissolves, filters and recovers common post-consumer waste plastics to produce recycled polymer pellets that can replace virgin plastics across multiple industries.
Circular EconomyCleantechNew MaterialsLivingston, GB
Tom Rose(CEO)
Rubedo Life Sciences develops therapeutics targeting aging by eliminating senescent cells to extend human healthspan.
AI & Machine LearningBiotechLongevityMedical Devices
Co-investorsCDP Venture CapitalEvolution VenturesKhosla VenturesLongeVCModi VenturesMoonstone Venture Capital+1 more
S-Biomedic conducts R&D on microbiome-based skincare, developing products that target and rebalance the skin microbiome to support skin health.
BiotechHealthtechWellness & Fitness
Turbine develops computational simulations of cells to accelerate drug discovery and development in oncology, using in silico predictions validated through wet lab experiments.
AI & Machine LearningBiotechDeep Tech
Szabolcs Nagy(Founder)in
Co-investorsAtlanticCrane Venture PartnersInteractive Venture Partners LlcAlpha EdisonFin CapitalSozo Ventures+2 more
Vincere develops therapeutics for age-related diseases such as Parkinson's and kidney disease, using a computational platform that combines human genetics, cellular network models, and in-silico biology to identify drug targets like USP30 for mitochondrial repair.
AI & Machine LearningBiotechLongevity
Co-investorsBeresford VenturesPortal InnovationsquadraScope Venture Fund
YZR Capital is a founder-led, independent investment platform focused on healthcare innovation, backing early-stage to growth-stage companies across Europe.
Munich, DE
Co-investorsPeakWave Ventures
Portfolio news
latest coverage across their companies
Evommune · stocktitan.net · Aug 6, 2026
YZR Capital · johngannonblog.com · Jul 24, 2026
Turbine · forbes.com · Jun 29, 2026
Rubedo Life Sciences · fightaging.org · Apr 8, 2026
Melt&Marble · finsmes.com · Dec 8, 2025
DePoly · s-ge.com · Nov 4, 2025
Frequently asked questions
- How many investments has Beiersdorf Innovation Fund made?
- Beiersdorf Innovation Fund has 17 tracked investments.
- What stage does Beiersdorf Innovation Fund invest at?
- Beiersdorf Innovation Fund invests at the Seed, Series A, Series B, Growth stages.
- What is Beiersdorf Innovation Fund's typical check size?
- Beiersdorf Innovation Fund typically writes checks of $550K – $5.5M.
- What sectors does Beiersdorf Innovation Fund focus on?
- Beiersdorf Innovation Fund focuses on AI & Machine Learning, Biotech, Climate Tech, Consumer, Healthtech, Impact & Social Good, Wellness & Fitness.
- Where is Beiersdorf Innovation Fund located?
- Beiersdorf Innovation Fund is headquartered in Hamburg, DE.
- Does Beiersdorf Innovation Fund lead rounds?
- Beiersdorf Innovation Fund typically participates in rounds rather than leading them.
- Who does Beiersdorf Innovation Fund co-invest with?
- Beiersdorf Innovation Fund most often shares deals with Crane Venture Partners, B Capital Group, Entrepreneur First, among 33 tracked co-investors.
Images
Similar investors
Better Ventures is an early-stage venture capital firm backing mission-driven technology companies working to build a better world across climate, health, and workforce sectors.
Obvious is a venture capital firm focused on supporting founders building solutions to humanity's largest challenges across planetary health, human health, and economic health.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Korys is the entrepreneurial investment company of the Colruyt family, investing long-term in companies as active investors and entrepreneurs.
Giant Ventures Global LLP is a venture capital firm that invests in technology companies. The firm focuses on founders addressing global challenges.


